Paper8652248
Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
Berger CC and 4 others. Eur J Cancer, 1995. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. Papers, record 8652248. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8652248
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Raynaud Disease | Major topic |
| Seminoma | Major topic |
| Testicular Neoplasms | Major topic |
| Vascular Diseases | Major topic |
| Adult | |
| Bleomycin | |
| Blood Flow Velocity | |
| Cisplatin | |
| Etoposide | |
| Fingers | |
| Humans | |
| Male | |
| Middle Aged | |
| Plethysmography | |
| Risk Factors | |
| Vinblastine |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00161174 | Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity | Background |
Source ClinicalTrials.gov
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38249337 | Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort study. | Ther Adv Med Oncol | 2024 | https://conductscience.org/library/papers/38249337 | PubMed |
| 35905486 | Testicular cancer survivorship: Long-term toxicity and management. | Can Urol Assoc J | 2022 | https://conductscience.org/library/papers/35905486 | PubMed |
| 32631603 | Cancer and Scleroderma. | Rheum Dis Clin North Am | 2020 | https://conductscience.org/library/papers/32631603 | PubMed |
| 32190815 | Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management. | JNCI Cancer Spectr | 2020 | https://conductscience.org/library/papers/32190815 | PubMed |
| 29264402 | Mechanistic and clinical insights at the scleroderma-cancer interface. | J Scleroderma Relat Disord | 2017 | https://conductscience.org/library/papers/29264402 | PubMed |
| 27885347 | Fludarabine Treatment of Patient with Chronic Lymphocytic Leukemia Induces a Digital Ischemia. | Case Rep Hematol | 2016 | https://conductscience.org/library/papers/27885347 | PubMed |
| 27421216 | Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link. | Best Pract Res Clin Rheumatol | 2016 | https://conductscience.org/library/papers/27421216 | PubMed |
| 26949933 | Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers. | Br J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26949933 | PubMed |
| 26352736 | Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening. | Curr Opin Rheumatol | 2015 | https://conductscience.org/library/papers/26352736 | PubMed |
| 26347114 | Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors. | Ann Oncol | 2015 | https://conductscience.org/library/papers/26347114 | PubMed |
| 23345497 | Old drugs: new complications. | BMJ Case Rep | 2013 | https://conductscience.org/library/papers/23345497 | PubMed |
| 23273834 | Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain. | J Pain | 2013 | https://conductscience.org/library/papers/23273834 | PubMed |
| 22956534 | Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity. | Oncologist | 2012 | https://conductscience.org/library/papers/22956534 | PubMed |
| 21825998 | Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications. | Curr Opin Rheumatol | 2011 | https://conductscience.org/library/papers/21825998 | PubMed |
| 21505757 | Does cisplatin-based chemotherapy effect on blood lipid levels of patients with germ cell testicular tumor in long-term follow-up? | Int Urol Nephrol | 2011 | https://conductscience.org/library/papers/21505757 | PubMed |
| 20506513 | Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. | Arthritis Rheum | 2010 | https://conductscience.org/library/papers/20506513 | PubMed |
| 19940282 | Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors. | J Natl Cancer Inst | 2009 | https://conductscience.org/library/papers/19940282 | PubMed |
| 19517112 | Paraneoplastic Raynaud's phenomenon in a breast cancer survivor. | Rheumatol Int | 2010 | https://conductscience.org/library/papers/19517112 | PubMed |
| 17322957 | Extensive deep vein thrombosis as a complication of testicular cancer treated with the BEP protocol (bleomycin, etoposide and cisplatin): case report. | Sao Paulo Med J | 2006 | https://conductscience.org/library/papers/17322957 | PubMed |
| 16620142 | Advances in the treatment of testicular cancer. | Drugs | 2006 | https://conductscience.org/library/papers/16620142 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8652248
GET https://conductscience.org/api/papers/v1/8652248/cited_by?page=2